Signos Glucose Monitoring System
Mar 2025
65d
Signos, Inc. has submitted 1 FDA 510(k) premarket notifications since 2025, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Integrated Continuous Glucose Monitor For Non-intensive Glucose Monitoring, Over-the-counter . Use the specialty filter in the sidebar to narrow results.